Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.50
+0.02001.35%
Post-market: 1.570.0700+4.67%19:03 EDT
Volume:227.31K
Turnover:341.70K
Market Cap:74.36M
PE:-1.28
High:1.78
Open:1.50
Low:1.48
Close:1.48
Loading ...

Sector Update: Health Care Stocks Slide in Afternoon Trading

MT Newswires Live
·
12 Mar

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger

MT Newswires Live
·
11 Mar

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences

Business Wire
·
11 Mar

Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3

MT Newswires Live
·
05 Mar

Hold Rating on Quanterix-Akoya Merger Amid Uncertainties and Potential Synergies

TIPRANKS
·
05 Mar

Akoya Biosciences downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
05 Mar

U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International

Reuters
·
05 Mar

Akoya Biosciences Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $2.4 From $3

THOMSON REUTERS
·
05 Mar

Quanterix Announces Acquisition of Akoya Biosciences

TIPRANKS
·
04 Mar

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Business Wire
·
03 Mar

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Business Wire
·
03 Mar

Akoya Biosciences Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
28 Feb

Kent Lake: to Nominate Directors to Quanterix Board in 2025 Annual Meeting

THOMSON REUTERS
·
19 Feb

Kent Lake Pr Llc: Believes Merger Agreement With Akoya Biosciences Significantly Undervalues Quanterix

THOMSON REUTERS
·
19 Feb

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company’s Proposed Merger with Akoya Biosciences

Business Wire
·
19 Feb

Akoya Biosciences unveils strategic product roadmap

TipRanks
·
06 Feb